Jubilant Organosys has strategically aligned its two entities, U.S.-based HollisterStier Laboratories and Canada-based Draxis Specialty Pharmaceuticals, and has assigned new leadership roles. The alignment is in an effort to leverage the strengths of these companies in the area of contract manufacturing of sterile injectables and non-sterile products and specialty pharmaceuticals. The unified operations will focus on R&D and product innovation for specialty pharmaceuticals, and will consolid...